Literature DB >> 12695345

Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.

Hong Lu1, Xiaofeng Meng, Chung S Yang.   

Abstract

(-)-Epigallocatechin gallate (EGCG) and (-)-epigallocatechin (EGC) are the major polyphenolic constituents in green tea. In this study, we characterized the enzymology of cytosolic catechol-O-methyltransferase (COMT)-catalyzed methylation of EGCG and EGC in humans, mice, and rats. At 1 microM, EGCG was readily methylated by liver cytosolic COMT to 4"-O-methyl-EGCG and then to 4',4"-di-O-methyl-EGCG; EGC was methylated to 4'-O-methyl-EGC. The K(m) and V(max) values for EGC methylation were higher than EGCG; for example, with human liver cytosol, the K(m) were 4.0 versus 0.16 microM and V(max) were 1.28 versus 0.16 nmol/mg/min. Rat liver cytosol had higher COMT activity than that of humans or mice. The small intestine had lower specific activity than the liver in the methylation of EGCG and EGC. Glucuronidation on the B-ring or the D-ring of EGCG greatly inhibited the methylation on the same ring, but glucuronidation on the A-ring of EGCG or EGC did not affect their methylation. Using EGC and 3,4-dihydroxy-L-phenylalanine as substrates, EGCG, 4"-O-methyl-EGCG, and 4',4"-di-O-methyl-EGCG were all potent inhibitors (IC(50) approximately 0.2 microM) of COMT. The COMT-inhibiting activity of (-)-EGCG-3'-O-glucuronide was similar to EGCG, but (-)-EGCG-4"-O-glucuronide was less potent. The present work provides basic information on the methylation of EGCG and suggests that EGCG may inhibit COMT-catalyzed methylation of endogenous and exogenous compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695345     DOI: 10.1124/dmd.31.5.572

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  77 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

2.  Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

Authors:  Piwen Wang; William J Aronson; Min Huang; Yanjun Zhang; Ru-Po Lee; David Heber; Susanne M Henning
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

3.  Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.

Authors:  Jia Zhang; Shufang Nie; Shu Wang
Journal:  J Agric Food Chem       Date:  2013-09-10       Impact factor: 5.279

4.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

5.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

Authors:  Joshua D Lambert; Mary J Kennett; Shengmin Sang; Kenneth R Reuhl; Jihyeung Ju; Chung S Yang
Journal:  Food Chem Toxicol       Date:  2009-10-31       Impact factor: 6.023

6.  Combined Effects of Ephedrine-Containing Dietary Supplements, Caffeine, and Nicotine on Morphology and Ultrastructure of Rat Hearts.

Authors:  Christopher E Brown; Stanley E Trauth; Richard S Grippo; Bill J Gurley; Anne A Grippo
Journal:  J Caffeine Res       Date:  2012-09

Review 7.  Pharmacokinetic and chemoprevention studies on tea in humans.

Authors:  H-H Sherry Chow; Iman A Hakim
Journal:  Pharmacol Res       Date:  2011-05-20       Impact factor: 7.658

8.  Inhibition of starch digestion by the green tea polyphenol, (-)-epigallocatechin-3-gallate.

Authors:  Sarah C Forester; Yeyi Gu; Joshua D Lambert
Journal:  Mol Nutr Food Res       Date:  2012-10-05       Impact factor: 5.914

9.  Structural identification of novel glucoside and glucuronide metabolites of (-)-epigallocatechin-3-gallate in mouse urine using liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Shengmin Sang; Chung S Yang
Journal:  Rapid Commun Mass Spectrom       Date:  2008-11       Impact factor: 2.419

Review 10.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.